Tumor shrinkage rate as a potential marker for the prediction of long-term outcome in advanced non-small cell lung cancer treated with first-line tyrosine kinase inhibitors
J Cancer Res Ther
; 2020 Jan; 15(6): 1574-1580
Article
| IMSEAR
| ID: sea-213573
Texto completo:
1
Índice:
IMSEAR
Tipo de estudio:
Prognostic_studies
Revista:
J Cancer Res Ther
Asunto de la revista:
Neoplasms
/
Therapeutics
Año:
2020
Tipo del documento:
Article